Published: 08 October 2026. The English Chronicle Desk. The English Chronicle Online
A 19-year-old teenager has become the first person in the UK to undergo a testicular tissue transplant, in a pioneering medical procedure that could eventually offer boys affected by chemotherapy a chance of having biological children.
The operation, carried out by a team of NHS specialists in Edinburgh, represents a significant development in fertility preservation. The young man had testicular tissue removed and frozen three years ago, before he began chemotherapy for a serious blood disorder. After completing treatment, medical tests showed that he had no sperm in his semen, confirming the devastating impact the therapy had had on his reproductive function.
Doctors have now transplanted the previously preserved tissue back into his body. The hope is that the tissue will become functional and eventually produce sperm. It remains too early to know whether the procedure will succeed, but specialists expect to have an indication within several months.
For the young man, who has chosen not to reveal his identity, the procedure represents more than a scientific experiment. It has restored a possibility he had increasingly feared was no longer available to him.
“Fertility is something I’ve struggled with personally for a long time,” he said, explaining that he had always wanted to have children of his own. As the years passed following his treatment, however, he began to accept the possibility that biological parenthood might never be possible.
The transplant has changed that outlook. Although neither the patient nor his doctors yet know whether the preserved tissue will successfully produce viable sperm, he said simply having a possibility of fatherhood again had given him genuine hope for the future.
The young man also expressed gratitude to the medical team and his family, while saying he hoped his participation in the research could eventually benefit other children facing similar circumstances.
Chemotherapy can be lifesaving for children and teenagers with cancer and other serious illnesses, but some chemotherapy drugs can cause permanent damage to the reproductive cells inside the testes. When this happens before or around puberty, the consequences may not become apparent until many years later, when the patient reaches adulthood and wants to have children.
For older teenagers and adult men, sperm freezing is already an established method of preserving fertility before treatment. Boys who have not yet reached puberty, however, generally cannot provide a semen sample containing mature sperm. This has created a major challenge for doctors seeking to protect their future fertility.
The Edinburgh procedure is designed to address that gap.
The tissue removed from the patient’s testicle contains spermatogonial stem cells. These cells are capable of developing into sperm-producing cells after puberty. By collecting and freezing the tissue before chemotherapy, doctors hope to preserve the biological material necessary for future sperm production.
The tissue can potentially be stored for many years and, if medical research establishes that it is safe and effective, returned to the patient’s body when he is older. The objective is for the transplanted tissue to reconnect with the body’s hormonal and reproductive systems and resume the process of sperm production.
The operation in Edinburgh took place in August and is the first reported testicular tissue transplant involving a teenager in the UK. It is also only the second reported procedure of its kind worldwide, highlighting how experimental the approach remains.
Professor Rod Mitchell, a developmental endocrinology specialist at the University of Edinburgh and consultant paediatric endocrinologist at NHS Lothian, said the procedure marked an important stage in a research programme that began a decade ago.
The Edinburgh team began investigating the possibility of removing and storing small pieces of testicular tissue from boys before they underwent chemotherapy. The long-term goal has been to develop a method that could preserve reproductive potential at a time when conventional sperm banking is impossible.
The researchers are now waiting to see whether the transplanted tissue in the 19-year-old begins producing viable sperm. Results could emerge within months, although determining whether the sperm are suitable for future fertility may require further investigation.
The procedure was carried out by medical specialists at NHS Lothian with support from Children with Cancer UK. It follows years of laboratory research and clinical development at the University of Edinburgh, where scientists have worked to understand how immature testicular tissue can be preserved and potentially restored after cancer treatment.
Tracey Gillies, medical director at NHS Lothian, described the operation as a landmark procedure and said it could represent an important advance for children whose fertility may be affected by treatment needed to overcome serious illnesses.
She also praised the patient and his family for agreeing to participate in research that could eventually change fertility care for other young people.
The Edinburgh development follows another significant breakthrough reported earlier this year. A man whose testicular tissue had been frozen when he was a child before chemotherapy later had the tissue transplanted back into his body. Sixteen years after it was originally preserved, the tissue was found to have produced sperm.
That case provided important evidence that testicular tissue collected before puberty can potentially retain its reproductive capacity after many years in frozen storage and following transplantation.
Together, the cases are encouraging researchers that fertility preservation may eventually become a routine part of care for boys facing treatments that could damage their reproductive systems.
The scale of the research effort is already considerable. More than 1,200 patients in the UK and about 3,100 worldwide have had testicular tissue stored for possible future use. Many of these patients were children who could not benefit from conventional sperm freezing because they had not yet reached puberty.
For families confronting a serious diagnosis, fertility preservation can be difficult to think about. The immediate priority is understandably survival, and chemotherapy or other intensive treatments may need to begin quickly. Yet advances in childhood cancer survival mean that increasing numbers of young people are growing into adulthood after successful treatment. Protecting their quality of life and future reproductive choices has therefore become an increasingly important part of long-term care.
The new transplant does not yet mean that every child who has stored testicular tissue will eventually be able to have biological children. Researchers still need to establish whether transplanted tissue can consistently produce healthy sperm, whether that sperm can safely be used to achieve pregnancy, and how best to manage potential risks associated with the procedure.
There are also important questions about when the tissue should be transplanted, how much tissue is required, and how doctors can ensure that stored tissue is safe to return to patients who have recovered from cancer or other serious diseases.
Nevertheless, specialists regard the latest operation as an important step because it moves the research beyond laboratory investigation and tissue storage toward restoring reproductive function in an individual patient.
For the 19-year-old at the centre of the procedure, the significance is deeply personal. After facing a serious illness, undergoing chemotherapy and later discovering that he had no sperm, the prospect of biological fatherhood had seemed increasingly remote.
Now, while the outcome remains uncertain, he has another possibility to hold on to.
His experience could also help shape the future of fertility care for thousands of children who undergo treatments capable of damaging their reproductive systems. If the transplanted tissue successfully produces viable sperm, the procedure could become an important part of a new generation of fertility-preservation strategies, giving boys and their families something that was previously difficult to offer: the possibility of preserving a future family life before lifesaving treatment begins.
For doctors and researchers, the months ahead will be closely watched. For the patient, they represent a period of waiting and hope, with the potential outcome carrying consequences that extend far beyond a single medical procedure.




























































































